Zhengyu Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhengyu Ge has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Fernandez-Ruiz
Affiliations Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia, Department of Molecular Medicine, Faculty of Medicine & Health, School of Biomedical Sciences, The University of New South Wales, Sydney, New South Wales, Australia, UNSW RNA Institute, The University of New South Wales, Sydney, New South Wales, Australia
3 shared publications - William R. Heath
Affiliation Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia
3 shared publications Anton Cozijnsen
School Of Biosciences, University of Melbourne, Parkville, Australia
2 shared publications- Calvin Xu
Department of Microbiology & Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia
2 shared publications Geoffrey I. McFadden
School Of Biosciences, University of Melbourne, Parkville, Australia
2 shared publications- Ian Andrew Cockburn
The Australian National University
2 shared publications
Latest Publications
- Open Access
- 30 January 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (2) , 295-307
γδ T cell-derived IL-4 initiates CD8+ T cell immunity
Dendritic cells (DCs) are pivotal for initiating adaptive immunity, a process triggered by the activation of DCs via pathogen products or damage. Immunization with sporozoites from Plasmodium leads to CD8 + T cell priming in a response initiated by collaboration between conventional type 1 DCs (cDC1s) and γδ T cells. Here we show that Vγ1 + γδ T cells have an initiating role by directly supplying interleukin-4 (IL-4). IL-4 and interferon-γ (IFNγ) synergize with CD4 + T cell-derived CD40L to induce IL-12 production by cDC1. Both IL-12 and IL-4 then directly signal responding CD8 + T cells and drive enhanced IL-12 receptor expression and expansion. This study shows how Vγ1 + γδ T cells can initiate CD8 + T cell immunity to Plasmodium and that responses to some pathogens require help from innate-like T cells to pass an initiation threshold and further amplify the response in a process underscored by IL-4 production.
- 30 January 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (2) , 295-307
Open Accessγδ T cell-derived IL-4 initiates CD8+ T cell immunity
Dendritic cells (DCs) are pivotal for initiating adaptive immunity, a process triggered by the activation of DCs via pathogen products or damage. Immunization with sporozoites from Plasmodium leads to CD8 + T cell priming in a response initiated by collaboration between conventional type 1 DCs (cDC1s) and γδ T cells. Here we show that Vγ1 + γδ T cells have an initiating role by directly supplying interleukin-4 (IL-4). IL-4 and interferon-γ (IFNγ) synergize with CD4 + T cell-derived CD40L to induce IL-12 production by cDC1. Both IL-12 and IL-4 then directly signal responding CD8 + T cells and drive enhanced IL-12 receptor expression and expansion. This study shows how Vγ1 + γδ T cells can initiate CD8 + T cell immunity to Plasmodium and that responses to some pathogens require help from innate-like T cells to pass an initiation threshold and further amplify the response in a process underscored by IL-4 production.
- Top Cited Papers
- 20 July 2023
- Published by Springer Nature in Nature Immunology
- Vol. 24 (9) , 1487-1498
mRNA vaccine against malaria tailored for liver-resident memory T cells
Malaria is caused by Plasmodium species transmitted by Anopheles mosquitoes. Following a mosquito bite, Plasmodium sporozoites migrate from skin to liver, where extensive replication occurs, emerging later as merozoites that can infect red blood cells and cause symptoms of disease. As liver tissue-resident memory T cells (Trm cells) have recently been shown to control liver-stage infections, we embarked on a messenger RNA (mRNA)-based vaccine strategy to induce liver Trm cells to prevent malaria. Although a standard mRNA vaccine was unable to generate liver Trm or protect against challenge with Plasmodium berghei sporozoites in mice, addition of an agonist that recruits T cell help from type I natural killer T cells under mRNA-vaccination conditions resulted in significant generation of liver Trm cells and effective protection. Moreover, whereas previous exposure of mice to blood-stage infection impaired traditional vaccines based on attenuated sporozoites, mRNA vaccination was unaffected, underlining the potential for such a rational mRNA-based strategy in malaria-endemic regions.
- 20 July 2023
- Published by Springer Nature in Nature Immunology
- Vol. 24 (9) , 1487-1498
Top Cited PapersmRNA vaccine against malaria tailored for liver-resident memory T cells
Malaria is caused by Plasmodium species transmitted by Anopheles mosquitoes. Following a mosquito bite, Plasmodium sporozoites migrate from skin to liver, where extensive replication occurs, emerging later as merozoites that can infect red blood cells and cause symptoms of disease. As liver tissue-resident memory T cells (Trm cells) have recently been shown to control liver-stage infections, we embarked on a messenger RNA (mRNA)-based vaccine strategy to induce liver Trm cells to prevent malaria. Although a standard mRNA vaccine was unable to generate liver Trm or protect against challenge with Plasmodium berghei sporozoites in mice, addition of an agonist that recruits T cell help from type I natural killer T cells under mRNA-vaccination conditions resulted in significant generation of liver Trm cells and effective protection. Moreover, whereas previous exposure of mice to blood-stage infection impaired traditional vaccines based on attenuated sporozoites, mRNA vaccination was unaffected, underlining the potential for such a rational mRNA-based strategy in malaria-endemic regions.
- Open Access
- 1 January 2021
- Published by Elsevier in Current Research in Immunology
- Vol. 2, 79-92
Plasmodium berghei Hsp90 contains a natural immunogenic I-Ab-restricted antigen common to rodent and human Plasmodium species
- 1 January 2021
- Published by Elsevier in Current Research in Immunology
- Vol. 2, 79-92
Open AccessPlasmodium berghei Hsp90 contains a natural immunogenic I-Ab-restricted antigen common to rodent and human Plasmodium species